MIP Discovery is a technology leader in the field of Molecularly Imprinted Polymers (MIPs). They have developed a novel, proprietary design, and development process to make nanoMIPs; nanostructured polymer particles typically containing a single binding site for the target of choice. NanoMIPs are a viable alternative to antibodies within the IVD sector, offering high performance, robust characteristics, and a reliable, ethical supply.
Address United Kingdom
Microbiology Product Areas
ClinicalNOTE: The products listed in this section may not be approved for clinical diagnostic use in your jurisdiction. You must assume these products are unregulated and therefore cannot be used for routine testing and reporting of results unless otherwise stated.
|Assay Development||Show all suppliers|